PATENT CLAIM ANALYSIS

Application Number: 15746254
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["540", "001000"]

Abstract:
Disclosed area fused ring pyrimidine compound, and an intermediate, a preparation method, a composition and a use thereof. The fused ring pyrimidine compound is a compound as shown in formula I, a tautomer, an enantiomer, a diastereoisomer, a pharmaceutically acceptable salt, a metabolite, a metabolic precursor or a prodrug thereof, wherein the above-mentioned compound is used for the preparation of a medicine for preventing, remitting or treating one or more of immune system diseases, autoimmune diseases, cell proliferative diseases, allergic disorders and cardiovascular diseases, and the compound has a strong inhibitory effect on the Janues kinase, FGFR kinase, FLT3 kinase and Src family kinase.

Claim (Index 10):
The fused ring pyrimidine compound, the tautomer, the enantiomer, the diastereoisomer, the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the prodrug thereof according to  claim 1 , which is selected from the group consisting of

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.83582
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14391386', '15025618', '15559181', '15568999', '15314938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7742246510773599
- 35 USC 102 Novelty (BERT): 0.5271976814295596
- Combined Prediction Score: 0.7495219541125799
- Mean Citation Score: 330.97676
- Max Citation Score: 348.54816
- Similarity Product: 289.7700724993515

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test